Abstract
The various isoforms of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) are responsible for the Ca2+ uptake from the cytosol into the endoplasmic or sarcoplasmic reticulum (ER/SR). In some tissues, the activity of SERCA can be modulated by binding partners, such as phospholamban and sarcolipin. The activity of SERCA can be characterized by its apparent affinity for Ca2+ as well as maximal enzymatic velocity. Both parameters can be effectively determined by the protocol described here. Specifically, we describe the measurement of the rate of oxalate-facilitated 45Ca uptake into the SR of crude mouse ventricular homogenates. This protocol can easily be adapted for different tissues and animal models as well as cultured cells.
Access provided by CONRICYT – Journals CONACYT. Download protocol PDF
Similar content being viewed by others
Key words
1 Introduction
The ability to mobilize Ca2+ has been, for decades, a well-established characteristic of ER/SR microsomes [1–3]. This observation was of particular importance in muscle tissue where Ca2+ is the trigger for contraction [4, 5]. This Ca2+ uptake activity was later determined to be produced by an integral membrane ATPase protein, SERCA [6–8]. Further research identified phospholamban [9, 10], and later sarcolipin [11, 12], as inhibitors of SERCA activity in cardiac and skeletal muscles, respectively.
SERCA activity follows traditional Michaelis-Menten enzyme kinetics [13] described by the equation
Here v is the observed rate and [S] is the concentration of rate-limiting substrate, which is Ca2+ in this case. In other words, the rate of Ca2+ binding to SERCA is the determinant of SERCA activity. (ATP is also a critical substrate for SERCA, but generally is well above saturating concentrations and therefore not rate limiting and not included in basic descriptions of SERCA activity). V max is the maximal rate of the enzyme and K m is the Michaelis constant which corresponds to the substrate concentration at the half maximal rate. K m is an inverse measure of substrate affinity, meaning that a low value corresponds to a high affinity and vice versa. In simpler terms — at low Ca2+ concentrations, where little is available to be pumped across the membrane, SERCA activity is low. Elevating Ca2+ increases SERCA activity up to a maximal level.
The Ca2+ uptake protocol described here produces the Michaelis-Menten response curve of SERCA over the physiologically relevant Ca2+ concentrations (10 nM to 10 μM), which also corresponds to the full dynamic range of the enzyme [10] (Fig. 1). For easy visualization and discussion, Ca2+ concentrations are represented with pCa values, which correspond to the inverse log of the molar concentration.
Changes in PLN or SLN inhibition will generate a leftward or rightward shift in this activity curve signifying an altered Ca2+ affinity. V max typically varies depending on SERCA expression level. Variations in K m and V max will also vary between species, tissue type, and SERCA isoform.
The protocol presented here is a detailed description of our standard laboratory procedure [14–20] and is adapted from the Millipore filtration technique [21]. In principle, this assay measures the amount of 45Ca retained in homogenate microsomes over time after being transported by SERCA . These microsomes are collected by a nitrocellulose membrane and subsequently washed to allow excess Ca2+ that is not sequestered by the microsomes to pass through. Ruthenium Red blocks extrusion of Ca2+ out of the microsomes through ion channels [22] and prevents uptake into the mitochondria [23]. Ca2+ precipitates with oxalate inside ER/SR microsomes [24–26], which serves multiple purposes in this assay. First, this precipitation lowers the free Ca2+ inside the microsomes, which eliminates the generation of a concentration gradient that would slow SERCA activity over time, thereby allowing consistent Ca2+ transport for the duration of the assay [27, 28]. Secondly, it further prevents Ca2+ extrusion out of the microsomes. Oxalate also preferentially accumulates in ER/SR microsomes via a nonspecific anion transporter [24–26, 29]. Therefore, the oxalate-trapped Ca2+ resides in only ER/SR microsomes which eliminates the need for ER/SR purification that may introduce significant variability between samples.
It is important to note that this assay describes the initial rates of steady-state activity of SERCA [27], although the cytosolic environment is not at steady-state. Increased SERCA activity decreases cytosolic Ca2+ , thereby decreasing its own enzymatic activity.
2 Materials
2.1 Solutions
Prepare all stock solutions using ultrapure water and analytical grade reagents and store at 4 °C unless otherwise noted.
-
1.
Homogenization Buffer: Prepare on the day of the experiment according to Table 1 and keep on ice until use.
-
2.
Reaction Mixture: Prepare on the day of the experiment according to Table 2 and keep on ice until use.
-
3.
0.1 M ATP : For 75 mL, dissolve 4.27 g ATP (MW 569.1 g/mol) in 40 mL of H2O and adjust the pH to 7.0 using 1 N NaOH. Keep on ice. Bring the volume to 70 mL. Calculate the true concentration by measuring and averaging the absorbance at 259 nm of multiple dilutions (1:1000–1:4000). M = Abs at 259 nm/15.4 × 103. Dilute the sample to exactly 0.1 M, aliquot, and store at −80 °C.
-
4.
1.14 × 10 −4 M Ruthenium Red: The day of the experiment, dilute approximately 0.1 mg in 1 mL of water. Calculate the true concentration by measuring the absorbance at 533 nm at multiple dilutions (1:100–1:300). M = Abs at 533 nm/6.4 × 104. Dilute the sample to 1.14 × 10−4 M. 400 μL are needed for each assay in duplicate.
-
5.
45 Ca: Prepare an initial stock of 45Ca to a concentration of 2.5 μCi/μL in H2O. For each assay in duplicate, 900 μL of 40 μCi/mL (36 μCi) is needed. 36 μCi corresponds to 14.4 μL of a 2.5 μCi/μL stock. To account for decay, divide 14.4 μL by the decay factor obtained from a 45Ca decay chart. Add H2O to bring final volume to 900 μL.
-
6.
10.00 mM CaCl 2 : Either purchase an analytical grade calcium solution or have the concentration of a prepared stock analytically verified.
-
7.
Wash Buffer: 20 mM Tris–HCl, 2 mM EGTA , pH 7.0.
-
8.
Tissue of Interest: This assay is optimized for whole mouse ventricular cardiac tissue (approximately 20 mg) and can be adapted for other tissue types or cultured cell lines. The abundance of SERCA protein, which is high in muscle, should be taken into account when adapting to non-muscle tissue or cells.
2.2 Equipment
-
1.
Vacuum filtration system.
-
2.
0.45 μm nitrocellulose Millipore filters.
-
3.
Water bath set to 37 °C.
-
4.
Reaction tubes: 15 × 85 mm borosilicate glass culture tubes.
-
5.
20 mL scintillation vials.
-
6.
Scintillation counter.
-
7.
Tissue homogenizer.
-
8.
Vortex.
3 Methods
3.1 Uptake Reaction
The key to this assay is consistent pipetting and great care should be taken to yield accurate and precise results. To further enhance accuracy, we recommend performing the entire assay in duplicate. Also, start at the lowest Ca2+ concentration and move to higher ones. On the duplicate set of reactions, start at the highest Ca2+ concentration and move to lower ones.
-
1.
Set up the 13 reaction tubes in duplicate (26 total).
-
2.
Set up 5 scintillation vials for each reaction: 1 blank, 1 standard, and 1 for each of the 3 time points (130 total).
-
3.
Prepare reaction tubes according to Table 3.
-
4.
Homogenize tissue in homogenization buffer and keep on ice until used for each reaction. 75 μL is necessary for each of the 26 reactions (1.950 mL total). Approximate protein concentration should be between 0.5 and 5.0 mg/mL. Final rates will be normalized to quantified concentration.
-
5.
Place four 0.45 μm Millipore filters on filtration manifold for the first reaction tube.
-
6.
Wash each filter two times with 2.5 mL Wash Buffer.
-
7.
Add 13.2 μL of 0.114 mM Ruthenium Red (1 μM final) to the first reaction tube.
-
8.
Add 75 μL of homogenates to the first reaction tube and slightly vortex (avoiding air bubble formation) to thoroughly mix.
-
9.
Place the reaction tube in a 37 °C water bath.
-
10.
After 30 s remove an aliquot of 290 μL for nonspecific binding (also called blank). Pass the aliquot through a 0.45 μm Millipore membrane.
-
11.
Initiate the reaction by adding 60 μL 0.1 M ATP , [Final] = 5 mM. Mix thoroughly with the pipet.
-
12.
Take out 300 μL at 30, 60, and 90 s time points and pass each aliquot through a different membrane.
-
13.
Wash each membrane two times with 2.5 mL wash buffer.
-
14.
Place the filters in the scintillation vials.
-
15.
Repeat steps 5–14 for the remaining reaction tubes.
-
16.
When finished, add 60 μL from the remaining reaction mixture to the standard scintillation vial for each reaction.
-
17.
Add 10 mL of scintillation fluid to each scintillation vial.
-
18.
Measure the samples with a scintillation counter.
3.2 Data Analysis
-
1.
Quantify homogenate protein concentration using the Bradford method.
-
2.
The scintillation counter yields values in counts per minute (cpm) which can be converted to moles of Ca2+ using the standard sample from step 16 in Subheading 3.1. This sample has not been filtered and therefore is representative of the total Ca2+ in each reaction mixture. The amount of microsome sequestered Ca2+ is represented by the following equation:
$$ \mathrm{C}\mathrm{a}\;\mathrm{Uptake}\left(\mathrm{nmol}\right)=\frac{\mathrm{sample}\;\mathrm{cpm}-\mathrm{blank}\;\mathrm{cpm}}{\mathrm{standard}\;\mathrm{cpm}\times 5}\times \mathrm{C}\mathrm{a}\left(\mathrm{nmol}\right) $$Here Ca (nmol) represents the amount of cold Ca2+ present in each aliquot (300 μL) of each individual reaction mixture (Table 3: 10.00 mM CaCl2 column) which is one-fifth of the amount in the total reaction mixture (1.5 mL).
-
3.
After all Ca-uptake values are calculated, perform a linear regression from the three time points (30, 60, and 90 s) for each pCa. The slope of this line corresponds to the rate of Ca2+ uptake in nanomole/minute. These values should then be normalized to the amount of protein giving a final normalized rate in nmol/min/mg (Fig. 2a).
-
4.
Plot the average of the duplicate calculations against the corresponding Ca2+ concentration. This plot can then be fit with the Hill equation to determine the V max and K m parameters (Fig. 2b).
4 Notes
-
1.
Be sure to follow the specific radiation safety guidelines at your facility for use and disposal of 45Ca.
-
2.
For consistency between assays, use the same batch of stock solutions for all experiments if possible.
-
3.
ATP and EGTA are critical for buffering Mg2+ and Ca2+ as changes in ATP concentration will cause variations in the free Ca2+ concentration.
-
4.
The stock CaCl2 solution is perhaps the most critical element in this assay and is essential for accurate Km measurements.
-
5.
Reaction tubes and scintillation vials can be organized and labeled the day prior to the assay.
-
6.
To limit the time spent in the radioactive lab and overall exposure, 45Ca should be added to the reaction mixture just prior to initiating the reaction.
-
7.
The 30, 60, and 90 s time points correspond to when the sample is passed through the membrane. To ensure proper timing, start a timer when adding ATP . Remove an aliquot from the reaction tube in water bath 5–6 s before each time point for transport to filtration system. Then pipet the sample exactly at 30, 60, and 90 s.
-
8.
Gently resuspend the reaction mixture before removing each aliquot to ensure even distribution of microsomes.
-
9.
Washing can be facilitated by a bottle top repeat dispenser.
-
10.
A 50× stock of wash buffer can be prepared and stored at 4 °C.
-
11.
For consistency between individual assays performed over multiple days, freeze a small aliquot from each homogenate and perform protein quantification for all samples simultaneously.
-
12.
Gently shake each scintillation vial to ensure that the membranes are fully submerged in scintillation fluid.
-
13.
For ease of analysis, a template spreadsheet should be generated.
-
14.
Calculated rates (slopes) with R 2 values less than 0.9 should be excluded from further analysis. These errors are likely due to inconsistent pipetting and/or inconsistent timing.
-
15.
K m values are generally consistent and may only require a few repetitions to generate statistical significance. V max values are more inconsistent, though reliable values can be obtained by additional repetitions. If necessary, data can be normalized to V max values.
References
Ebashi S, Lipmann F (1962) Adenosine triphosphate-linked concentration of calcium ions in a particulate fraction of rabbit muscle. J Cell Biol 14:389–400
Hasselbach W, Makinose M (1962) The calcium pump of the “relaxing granules” of muscle and its dependence on ATP-splitting. Biochem Z 333:518–528
Hasselbach W, Makinose M (1963) on the Mechanism of Calcium Transport Across the Membrane of the Sarcoplasmic Reticulum. Biochem Z 339:94–111
Gordon AM, Homsher E, Regnier M (2000) Regulation of contraction in striated muscle. Physiol Rev 80:853–924
Bers DM (2008) Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 70:23–49
MacLennan DH, Brandl CJ, Korczak B, Green NM (1985) Amino-acid sequence of a Ca2+ + Mg2 + -dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence. Nature 316:696–700
Brandl CJ, Green NM, Korczak B, MacLennan DH (1986) Two Ca2+ ATPase genes: homologies and mechanistic implications of deduced amino acid sequences. Cell 44:597–607
MacLennan DH (1970) Purification and properties of an adenosine triphosphatase from sarcoplasmic reticulum. J Biol Chem 245:4508–4518
Tada M, Kirchberger MA, Katz AM (1975) Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3′:5′-monophosphate-dependent protein kinase. J Biol Chem 250:2640–2647
MacLennan DH, Kranias EG (2003) Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4:566–577
Odermatt A, Becker S, Khanna VK et al (1998) Sarcolipin regulates the activity of SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2 + -ATPase. J Biol Chem 273:12360–12369
MacLennan DH, Asahi M, Tupling AR (2003) The regulation of SERCA-type pumps by phospholamban and sarcolipin. Ann N Y Acad Sci 986:472–480
Inesi G, Kurzmack M, Coan CR, Lewis DE (1980) Cooperative calcium binding and ATPase activation in sarcoplasmic reticulum vesicles. J Biol Chem 255:3025–3031
Haghighi K, Pritchard T, Bossuyt J et al (2012) The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase. J Mol Cell Cardiol 52:773–782
Schmidt AG, Zhai J, Carr AN et al (2002) Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure. Cardiovasc Res 56:248–259
Frank K, Tilgmann C, Shannon TR et al (2000) Regulatory role of phospholamban in the efficiency of cardiac sarcoplasmic reticulum Ca2+ transport. Biochemistry 39:14176–14182
Zhai J, Schmidt AG, Hoit BD et al (2000) Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo. J Biol Chem 275:10538–10544
Harrer JM, Haghighi K, Kim HW et al (1997) Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart. Am J Physiol 272:H57–H66
Szymanska G, Grupp IL, Slack JP et al (1995) Alterations in sarcoplasmic reticulum calcium uptake, relaxation parameters and their responses to beta-adrenergic agonists in the developing rabbit heart. J Mol Cell Cardiol 27:1819–1829
Zhao W, Waggoner JR, Zhang Z-G et al (2009) The anti-apoptotic protein HAX-1 is a regulator of cardiac function. Proc Natl Acad Sci U S A 106:20776–20781
Solaro RJ, Briggs FN (1974) Estimating the functional capabilities of sarcoplasmic reticulum in cardiac muscle. Circ Res 34:531–540
Chamberlain BK, Volpe P, Fleischer S (1984) Inhibition of calcium-induced calcium release from purified cardiac sarcoplasmic reticulum vesicles. J Biol Chem 259:7547–7553
Moore CL (1971) Specific inhibition of mitochondrial Ca++ transport by ruthenium red. Biochem Biophys Res Commun 42:298–305
Beil FU, von Chak D, Hasselbach W, Weber HH (1977) Competition between oxalate and phosphate during active calcium accumulation by sarcoplasmic vesicles. Z Naturforsch C 32:281–287
De Meis L, Hasselbach W, Machado RD (1974) Characterization of calcium oxalate and calcium phosphate deposits in sarcoplasmic reticulum vesicles. J Cell Biol 62:505–509
Feher JJ, Lipford GB (1985) Calcium oxalate and calcium phosphate capacities of cardiac sarcoplasmic reticulum. Biochim Biophys Acta 818:373–385
Madeira VM (1984) State of translocated Ca2+ by sarcoplasmic reticulum inferred from kinetic analysis of calcium oxalate precipitation. Biochim Biophys Acta 769:284–290
Inesi G, de Meis L (1989) Regulation of steady state filling in sarcoplasmic reticulum. Roles of back-inhibition, leakage, and slippage of the calcium pump. J Biol Chem 264:5929–5936
MacLennan DH, Reithmeier RA, Shoshan V et al (1980) Ion pathways in proteins of the sarcoplasmic reticulum. Ann N Y Acad Sci 358:138–148
Acknowledgement
This work was supported by NIH grants HL-26057 and HL-64018 to E. G. K. and AHA grant 13POST13860006 to P. A. B.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Bidwell, P.A., Kranias, E.G. (2016). Calcium Uptake in Crude Tissue Preparation. In: Bublitz, M. (eds) P-Type ATPases. Methods in Molecular Biology, vol 1377. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3179-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3179-8_16
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3178-1
Online ISBN: 978-1-4939-3179-8
eBook Packages: Springer Protocols